REXAHN PHARMACEUTICALS, INC. Purchase Agreements
28 Contracts & Agreements
- Purchase Agreement, dated as of August 10, 2023, by and between Ocuphire Pharma, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 11, 2023)
- Form of Securities Purchase Agreement, dated as of June 4, 2021, by and among Ocuphire Pharma, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on June 7, 2021)
- Form of Securities Purchase Agreement, dated as of June 4, 2021, by and among Ocuphire Pharma, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on June 4, 2021)
- Amended and Restated Securities Purchase Agreement, dated as of June 29, 2020, by and among Rexahn, Ocuphire and the investors party thereto (Filed With SEC on July 1, 2020)
- Securities Purchase Agreement, dated as of June 17, 2020, by and among Rexahn, Ocuphire and the investors party thereto (Filed With SEC on June 19, 2020)
- Form of Securities Purchase Agreement, dated as of October 17, 2018, by and between Rexahn Pharmaceuticals, Inc. and the purchasers signatory thereto (Filed With SEC on October 19, 2018)
- Form of Securities Purchase Agreement, dated as of October 13, 2017, by and between Rexahn Pharmaceuticals, Inc. and the purchasers signatory thereto (Filed With SEC on October 13, 2017)
- Form of Securities Purchase Agreement, dated as of June 6, 2017, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on June 7, 2017)
- Form of Securities Purchase Agreement, dated as of September 14, 2016, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on September 14, 2016)
- Form of Securities Purchase Agreement, dated as of February 26, 2016, by and between Rexahn Pharmaceuticals, Inc. and the investor in the offering (Filed With SEC on February 26, 2016)
- Form of Securities Purchase Agreement, dated as of November 6, 2015, by and between Rexahn Pharmaceuticals, Inc. and the investor in the offering (Filed With SEC on November 6, 2015)
- Form of Securities Purchase Agreement, dated as of January 15, 2014, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on January 15, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 24, 2013)
- Form of Securities Purchase Agreement, dated March 28, 2011, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on March 30, 2011)
- Amendment No. 2 to the Securities Purchase Agreement, dated January 19, 2011, by and between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited (Filed With SEC on January 20, 2011)
- Form of Securities Purchase Agreement, dated June 28, 2010, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on June 29, 2010)
- Securities Purchase Agreement, dated as of October 19, 2009, by and between Rexahn Pharmaceuticals, Inc. and the purchasers signatory thereto (Filed With SEC on October 20, 2009)
- Amendment No. 1 to Securities Purchase Agreement, dated as of September 16, 2009, by and between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited (Filed With SEC on September 21, 2009)
- Securities Purchase Agreement, dated as of June 26, 2009, by and between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited (Filed With SEC on September 21, 2009)
- Securities Purchase Agreement, dated as of June 26, 2009, by and between Rexahn Pharmaceuticals, Inc. and the purchaser named therein (Filed With SEC on June 30, 2009)
- Securities Purchase Agreement, dated as of May 19, 2009, by and between Rexahn Pharmaceuticals, Inc. and the purchaser signatory thereto (Filed With SEC on May 20, 2009)
- Securities Purchase Agreement, dated as of March 20, 2008, by and between Rexahn Pharmaceuticals, Inc. and Super Bio Co. Ltd., (the Super Bio Securities Purchase Agreement) (Filed With SEC on March 26, 2008)
- Securities Purchase Agreement, dated as of March 20, 2008, by and between Rexahn Pharmaceuticals, Inc. and Jungwoo Family Co., Ltd. (the Jungwoo Securities Purchase Agreement) (Filed With SEC on March 26, 2008)
- Securities Purchase Agreement, dated as of December 17, 2007, by and among Rexahn Pharmaceuticals, Inc. and the several parties signatory thereto (the Individual Investor... (Filed With SEC on December 18, 2007)
- Securities Purchase Agreement, dated as of December 17, 2007, by and between Rexahn Pharmaceuticals, Inc. and Kumho Investment Bank (the Kumho Securities Purchase Agreement) (Filed With SEC on December 18, 2007)
- Securities Purchase Agreement, dated as of December 17, 2007, by and between Rexahn Pharmaceuticals, Inc. and Jungwoo Family Co., Ltd. (the Jungwoo Securities Purchase Agreement) (Filed With SEC on December 18, 2007)
- Securities Purchase Agreement, dated as of November 20, 2007, by and between Rexahn Pharmaceuticals, Inc. and Rexgene Biotech Co., Ltd (Filed With SEC on November 21, 2007)
- Securities Purchase Agreement, dated as of November 19, 2007, by and between Rexahn Pharmaceuticals, Inc. and KT&G Corporation (Filed With SEC on November 21, 2007)
